Navigation Links
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
Date:12/11/2011

SAN DIEGO - A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the American Society of Hematology.

"PCI-32765, one of a new class of experimental drugs called B cell receptor inhibitors, has shown impressive potential in this clinical trial for its effectiveness and particularly for its relatively minimal toxicity," said lead investigator Susan O'Brien, M.D., professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.

According to the National Cancer Institute's Surveillance Epidemiology and End Results database, an estimated 14,570 people will receive a diagnosis of CLL in 2011 and about 4,380 patients will die of the disease.

Six-month progression free survival of 90-92 percent

Of 27 CLL patients treated at a dose of 420 milligrams daily, 70 percent had complete or partial remission at 10.2 months of median follow-up. Six-month progression-free survival was 92 percent. Patients received a median three prior treatments before entering the clinical trial.

At a higher dose of 840 mg, 44 percent of 34 patients achieved complete or partial remission at 6.5 months median follow-up, similar to the response rate of the lower-dose cohort at 6.2 months. Progression free survival at 6 months was 90 percent. Study participants had received a median of five prior treatments.

Overall, five patients (8 percent) of the 61 from both arms had progressive disease and 50 (82 percent) remained on the therapy.

Drug does not suppress blood cell production

CLL presently is treated with combination chemotherapies that can cause myelosuppression - inhibited bone marrow function leading to decreased production of blood cells. The resulting susceptibility to infection can be a problem for patien
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Toll-like receptors play role in brain damage in newborns
2. Folate receptors may serve as a front door to ovarian cancer treatment
3. Nuclear receptors battle it out during metamorphosis in new fruit fly model
4. Cell receptor could allow measles virus to target tumors
5. CSHL structural biologists reveal novel drug binding site in NMDA receptor subunit
6. Historic first images of rod photoreceptors in the living human eye
7. Older age memory loss tied to stress hormone receptor in brain
8. Entire T-cell receptor repertoire sequenced revealing extensive and unshared diversity
9. Researchers get a grip on nervous systems receptors
10. Feast or famine: Researchers identify leptin receptors sidekick as a target for appetite regulation
11. Targeting nicotine receptors to treat cognitive impairments in schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... are more easily distracted during thinking and memory tasks ... any type of memory test administered reveals a decline ... co-author Randi Martin, professor of psychology at Rice University, ... said, this study shows that "environmental interference" has a ... younger adults. The study included 60 seniors, aged ...
(Date:7/25/2014)... As reported by People Magazine in the article Mike ... Sober (7/15), one of the most popular cast stars ... the public about his personal transformation. Now, two years later ... moving on with his life was a challenge. He was ... 2012 and even spent some time in rehab. He took ...
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Ibuprofen and Oxcarbazepine Tablets . , The ... and one lot of Oxcarbazepine Tablets, by American Health Packaging ... is used for the treatment of certain types of seizures ... the recall is that Lot #142588, Expiration Date, 01/2016 of ...
(Date:7/25/2014)... 2014 Parker Waichman LLP, a national ... comments on a recent tobacco lawsuit in which a ... billion in punitive damages. Cynthia Robinson brought the lawsuit ... case is Cynthia Robinson v. R.J. Reynolds Tobacco Company ... Circuit Court, Escambia County, Florida; Case Number 2008 CA ...
(Date:7/25/2014)... Philadelphia, PA (PRWEB) July 25, 2014 ... that Valerie D. Weber, MD, MS, FACP, has been appointed ... , Weber will join Drexel from The Commonwealth Medical College, ... Sciences, associate dean for clinical affairs, and professor of medicine. ... of The Commonwealth Medical College, Weber had a major role ...
Breaking Medicine News(10 mins):Health News:Distractions Seem More Troublesome With Age 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3
... ... economic woes, budgets are tightening, banks aren,t lending and consumers aren,t ... people, and businesses are cringing at the sound of customers slamming ... economic downturn, and still others are continuing to experience rapid growth. ...
... ... dangerous drunk driving day of the year , ... Colorado Springs, CO (PRWEB) October 21, 2009 -- The members of McDivitt Law Firm care ... off the road this Halloween. , , , , ,McDivitt Law Firm is partnering with ...
... ... , ... 21, 2009 -- Aprima Medical Software (originally iMedica), a leading developer of electronic ... with Microsoft Windows 7 (32 and 64 bit PCs), due out for release on October ...
... Regence member Adrianne Johnson needed to find a primary care ... on to myRegence.com to compare those recommendations with feedback from ... on the Member Reviews she read on myRegence.com, Johnson was ... with, but specialists, as well. , "The reviews on ...
... (TSX: MDS; NYSE: MDZ ), a leading provider of ... announced that Company shareholders have approved the sale of its ... discovery and life sciences research tools, to Danaher Corporation (NYSE: ... of Shareholders was held on October 20, 2009, and in ...
... WASHINGTON, Oct. 20 Speaker Nancy Pelosi, House Majority ... Michigan held a press availability this afternoon in ... urgency of health insurance reform for children with pre-existing conditions. ... Jessica Segal of Texas told their ...
Cached Medicine News:Health News:Apple Vending is a Strong Growth Segment Despite Tough Economic Times 2Health News:Apple Vending is a Strong Growth Segment Despite Tough Economic Times 3Health News:McDivitt Law Firm's Treat Is No Trick -- Free Rides on Halloween in Colorado Springs 2Health News:McDivitt Law Firm's Treat Is No Trick -- Free Rides on Halloween in Colorado Springs 3Health News:Aprima 2009 First Electronic Health Record and Practice Management System to Announce Support for Microsoft Windows 7 2Health News:Regence Takes Community Approach to Provider 'Reviews' 2Health News:Regence Takes Community Approach to Provider 'Reviews' 3Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 2Health News:MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies 3Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 2Health News:Pelosi Remarks at Press Availability with Easter Seals on Benefits of Health Reform for Children 3
(Date:7/25/2014)... 2014  Corporate libraries are constantly being faced with ... technology and how to cope with flat or shrinking ... and medical device industries are increasingly finding it challenging ... they provide. According to recent research ... forces of change that leading corporate libraries are being ...
(Date:7/25/2014)... HILL, N.C. , July 25, 2014  In ... area is costly and challenging - as is managing ... Is it possible - or even ... together? If so, where can you combine resources and ... separated? These are just a few ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook to ... Endoscopy Systems market. The report provides value, in millions ... (in US dollars) within market segments: Photo ... Endoscopes , Capsule Endoscopy Data Recorders , ... provides company shares and distribution shares data for each ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... The low-profile 5107 Bariatric Stand-On Scale is ... lbs, while typical physicians scales only weigh ... regardless of floor surface, or patients position ... stable and low profile only 1 ...
... hormone (PTH) is synthesized by the ... response to decreased extracellular calcium concentrations. ... resorption and decreasing calcium excretion by ... circulation, intact PTH is rapidly degraded ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... a C19 steroid, is one of the ... postpubertal males, testosterone is secreted primarily by ... derived from peripheral conversion of androstenedione [2]. ... that over 50% of serum testosterone is ...
Medicine Products: